The board of CanSino Biologics Inc. announced that on February 7, 2023, the company entered into the CBHB Structured Deposit Agreement XIII with China Bohai Bank Co., Ltd. (CBHB), pursuant to which the Company agreed to purchase structured deposit in the principal amount of RMB 200 million from CBHB. Name of the product: CBHB WBS230167 Structured Deposit WBS230167. Term of deposit: From February 9, 2023 to August 14, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 HKD | +3.03% | +6.25% | -9.73% |
Apr. 23 | China Bohai Bank Issues 14 Billion Yuan Tier-II Capital Bonds | MT |
Apr. 16 | China Longyuan Power Raises 2 Billion Yuan from 86-Day Bond Issue | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.73% | 2.25B | |
+16.61% | 214B | |
+3.99% | 74.34B | |
+7.99% | 55.76B | |
+14.30% | 46.9B | |
-0.25% | 46.37B | |
+19.29% | 45.3B | |
+10.93% | 36.85B | |
-16.21% | 35.14B | |
-96.60% | 32.24B |
- Stock Market
- Equities
- 9668 Stock
- News China Bohai Bank Co., Ltd.
- Cansino Biologics Inc. Enters CBHB Structured Deposit Agreement XIII with China Bohai Bank Co., Ltd